A Multicenter, Phase 2 Study of Tesetaxel plus Three Different PD-(L)1 Inhibitors in Patients with Triple-Negative, Locally Advanced or Metastatic Breast Cancer and Tesetaxel Monotherapy in Elderly Patients with HER2 Negative, Locally Advanced or Metastatic Breast Cancer

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Park, John (Associate Investigator)
  • Gilchrist, Jenny (Associate Investigator)
  • Rai, Meenal (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleODO-TE-B202
AcronymCONTESSA
StatusActive
Effective start/end date1/05/20 → 31/12/21
View all
View less